However, no significant relationship was observed between the BARD1 expression level and the other clinical parameters, such as age, gender, family history, cirrhosis, tumor number, wine-drinking, metastasis, and recurrence (all P > 0.05, Table 1). This evidence concerns the gene BARD1 and neoplasm.